|
FDA Staff Travels on Drug Industry Dollars |
|
|
|
Thursday, 30 March 2006 |
|
The Center for Public Integrity reports that FDA officials circumvent the prohibition on accepting trips from drug and medical device manufacturers. |
|
Read more...
|
|
|
Are Drugs Always Needed for Schizophrenia? What does the Scientific Evidence Show? |
|
|
|
Thursday, 30 March 2006 |
“Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm?” An article in the Schizophrenia Bulletin, by Dr. John Bola that dares to question the validity of the unexamined treatment paradigm in schizophrenia:
|
|
Read more...
|
|
|
DAWN: "Disposition of Emergency Department Visits for Drug-Related Suicide Attempts by Adolescents: |
|
|
|
Wednesday, 29 March 2006 |
|
A report by the Drug Abuse Warning Network (DAWN), reveals some sobering facts about teenage suicide attempts that involve drugs. |
|
Read more...
|
|
|
Disasterous Drug Trial_FDA New Rules Ensure More Disasters to Follow |
|
|
|
Tuesday, 28 March 2006 |
|
Unless Congress acts to overrule the FDA, research disasters such as occurred in London, when six healthy men were exposed to an experimental substance that brought them close to death, are likely to occur with increased frequency. |
|
Read more...
|
|
|
Addictive Qualities of Modafinil Not Discussed by FDA Advisory |
|
|
|
Tuesday, 28 March 2006 |
|
The focus of a recent FDA's Psychopharmacology Advisory Committee meeting, was the drug, modafinil (as Sparlon), for ADHD and the risk of
Steven-Johnson's, a rare but potentially fatal, skin condition. |
|
Read more...
|
|
|
|
<< Start < Prev 61 62 63 64 65 66 67 68 69 70 Next > End >>
|
| Results 586 - 594 of 753 |
